Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/3381
Title: | NANOMEDICINE AND NANOCARRIERS FOR CANCER TREATMENT |
Authors: | Arunadevi, Natarajan Suyambulingam, Jone Kirubavathy |
Keywords: | Drug development drug delivery system pharmaceutics nanotechnology tumor toxicity materials application pharmaceutical therapy |
Issue Date: | 8-Feb-2023 |
Publisher: | Elsevier |
Abstract: | Nanomedicine and nanocarrier drug systems are innovative therapeutic concept in which drugs in nano dimensions are employed for diagnostic and treatment for carcinogenic cells. Nanomedicines are emerged as superlative drugs for cancer treatment due to their small size, good penetrating power, and high affinity for binding with drugs. The nanotechnology field provides numerous benefits as therapeutic agents like target drug delivery (DD) with minimal side effects. The current chapter presents the detailed study on different approaches for DD, approved nanocarriers drugs, active and passive targeting, and different kinds of challenges faced. The regulatory issues and safety concerns are also discussed, and this chapter improves the knowledge of cancer treatment with the use of nanotechnology. |
URI: | https://www.sciencedirect.com/science/article/abs/pii/B9780323953252000018 |
Appears in Collections: | National Journals |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
NANOMEDICINE AND NANOCARRIERS FOR CANCER TREATMENT.docx | 197.4 kB | Microsoft Word XML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.